The City Headlines
Ludhiana, November 6
The United States partner of Bharat Biotech’s Covaxin Ocugen has asked the USFDA (Food and Drug Administration) for Emergency Use Authorisation of Covaxin for children below the age of 18.
Sharing the details, Dr. Raches Ella, Bharat Biotech’s clinical lead for Covaxin, tweeted, “Due to tolerable safety profile, COVAXIN is ideally placed for children. We are pleased to announce our EUA filing to the US-FDA through our partners-Ocugen.”
Also read: Rs. 50,000 to heirs of those who died of Covid-19
(Published by- Manav Bansal)
